Hospitalization with varicella and shingles before and after introduction of childhood varicella vaccination in Germany

Human Vaccines and Immunotherapeutics

Volumn 10, Issue 12, 2014, Pages 3594-3600

  Siedler, Anette ^a   Dettmann, Marleen ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Germany; Hospitalization; Joinpoint regression; Shingles; Vaccination coverage; Varicella; Varicella vaccination

Indexed keywords

CHICKENPOX VACCINE; VARICELLA ZOSTER VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHICKENPOX; CHILD; DISEASE SURVEILLANCE; EPIDEMIOLOGICAL MONITORING; FEMALE; GERMANY; HEALTH IMPACT ASSESSMENT; HERPES ZOSTER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INFANT; INTERNATIONAL CLASSIFICATION OF DISEASES; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PRESCHOOL CHILD; SCHOOL CHILD; TIME TO TREATMENT; VACCINATION; YOUNG ADULT; AGE; IMMUNOLOGY; NEWBORN; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AGE FACTORS; CHICKENPOX; CHICKENPOX VACCINE; CHILD; CHILD, PRESCHOOL; GERMANY; HERPES ZOSTER; HOSPITALIZATION; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MIDDLE AGED; VACCINATION;

EID: 84922575259     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.34426     Document Type: Article

References (28)

1. Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut, Stand: Juli 2004. Epidemiologisches Bulletin 2004:235-49.
2. Robert Koch-Institut. Empfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut, Stand: Juli 2009. Epidemiologisches Bulletin 2009:279-98.
3. Rieck T, Feig M, Eckmanns T, Benzler J, Siedler A, Wichmann O. Vaccination coverage among children in Germany estimated by analysis of health insurance claims data. Human Vaccines & Immunotherapeutics 2013; 10:476-84.
4. Robert Koch-Institut. Stellungnahme der Ständigen Impfkommission (STIKO): Evaluation der Varizellen-Impfempfehlung durch die STIKO. Epidemiologisches Bulletin 2013:1-5.
5. Liese JG, Grote V, Rosenfeld E, Fischer R, Belohradsky BH, v Kries R, et al. The burden of varicella complications before the introduction of routine varicella vaccination in Germany. Pediatr Infect Dis J 2008; 27:119-24.
6. Wagenpfeil S, Neiss A, Banz K, Wutzler P. Empirical data on the varicella situation in Germany for vaccination decisions. Clinical Microbiology and Infection: 2004; 10:425-30.
7. Siedler A, Arndt U. Impact of the routine varicella vaccination programme on varicella epidemiology in Germany. Euro Surveill 2010; 15. http://www.eurosurveillance.org/images/dynamic/EE/V15N13/V15N13.pdf
8. Spackova M, Muehlen M, Siedler A. Complications of varicella after implementation of routine childhood varicella vaccination in Germany. Pediatr Infect Dis J 2010; 29:884-6.
9. Plotkin SA, Orenstein WA, Offit PA. Varicella Vaccine. Vaccines. Philadelphia Elsevier Saunders, 2013:1550.
10. Chickenpox/Herpes Zoster. In: Heymann DL, ed. Control of Communicable Disease Manual. Washington: American Public Health Association, 2008:109-16.
11. Ogunjimi B, Van Damme P, Beutels P. Herpes Zoster Risk Reduction through Exposure to Chickenpox Patients: A Systematic Multidisciplinary Review. PloS one 2013; 8:e66485.
12. van Hoek AJ, Melegaro A, Zagheni E, Edmunds WJ, Gay N. Modelling the impact of a combined varicella and zoster vaccination programme on the epidemiology of varicella zoster virus in England. Vaccine 2011; 29:2411-20.
13. Brisson M, Edmunds WJ, Gay NJ, Law B, De Serres G. Modelling the impact of immunization on the epidemiology of varicella zoster virus. Epidemiology and infection 2000; 125:651-69.
14. Poletti P, Melegaro A, Ajelli M, Del Fava E, Guzzetta G, Faustini L, et al. Perspectives on the impact of varicella immunization on herpes zoster. A model-based evaluation from three European countries. PloS one 2013; 8:e60732.
15. Siedler A, Hecht J, Rieck T, Tolksdorf K, Hengel H. [Varicella vaccination in Germany. A provisional appraisal in the context of MMR vaccination]. Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2013; 56:1313-20.
16. Diagnostic data of the hospitals by place of treatment, ICD-10: B01, B02, ICD-9: 052-053. https://www.gbe-bund.de/:Destatis, 2014.
17. Robert Koch-Institut. Impfquoten bei der Schuleingangsuntersuchung in Deutschland 2012. Epidemiologisches Bulletin 2014:137-41.
18. Lopez AS, Zhang J, Brown C, Bialek S. Varicellarelated hospitalizations in the United States, 2000-2006: the 1-dose varicella vaccination era. Pediatrics 2011; 127:238-45.
19. Tan B, Bettinger J, McConnell A, Scheifele D, Halperin S, Vaudry W, et al. The effect of funded varicella immunization programs on varicella-related hospitalizations in IMPACT centers, Canada, 2000-2008. Pediatr Infect Dis J 2012; 31:956-63.
20. Marshall HS, McIntyre P, Richmond P, Buttery JP, Royle JA, Gold MS, et al. Changes in patterns of hospitalized children with varicella and of associated varicella genotypes after introduction of varicella vaccine in Australia. Pediatr Infect Dis J 2013; 32:530-7.
21. Waye A, Jacobs P, Tan B. The impact of the universal infant varicella immunization strategy on Canadian varicella-related hospitalization rates. Vaccine 2013; 31:4744-8.
22. Siedler A, Ultsch B, Rieck T. Herpes zoster in children after introduction of universal childhood varicella vaccination in Germany. 29 Conference of the European Society for Pediatric Infectious Diseases (ESPID). The Hague, The Netherlands, 2011:1128. http://espid.kenes.com/Documents/ESPID2011%20ABSTRACTS.pdf
23. Civen R, Chaves SS, Jumaan A, Wu H, Mascola L, Gargiullo P, et al. The incidence and clinical characteristics of herpes zoster among children and adolescents after implementation of varicella vaccination. Pediatr Infect Dis J 2009; 28:954-9.
24. Chun C, Weinmann S, Riedlinger K, Mullooly JP, Houston H, Schmid DS, et al. Laboratory characteristics of suspected herpes zoster in vaccinated children. Pediatr Infect Dis J 2011; 30:719-21.
25. ECDC. Varicella vaccine in the European Union: Preliminary Guidance. http://www.ecdc.europa.eu/en/publications/Publications/Varicella-guidance-2014-consultation.pdf:ECDC, 2014.
26. The Information System of the Federal Health Monitoring. Population on an annual average. http://www.gbe-bund.de/:Destatis, 2014.
27. Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Statistics in medicine 2000; 19:335-51.
28. National Cancer Institute. Joinpoint Regression Program. Version 4.0.4. https://surveillance.cancer.gov/joinpoint/, 2013.